{ "items": [ "\n\n
\n \n\n \n \n \n \n MOCRU\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n20 February 2018
\n \n \n \nMyanmar-Oxford Clinical Research Unit (MOCRU) and partner Medical Action Myanmar (MAM) are performing a scrub typhus survey among fever patients attending the Puta-O clinic, a small, picturesque, secluded town surrounded by snow-capped Himalayan foothills in the far north of Myanmar over 1,500 km from Yangon.
\n \n\n \n \n\n \n\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n9 February 2018
\n \n \n \nOver two-thirds of meat samples from Ho Chi Minh City were found to contain Salmonella bacteria, according to a study by the Oxford University Clinical Research Unit (OUCRU). Researchers purchased 117 samples of chicken meat, beef and pork from retail sites in 2016-2017; 68.4% of those samples were found to contain Salmonella bacteria.
\n \n\n \n \n\n \n\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n6 February 2018
\n \n \n \nWho will step up during the next decade to implement and integrate life-saving interventions and services for newborns? Decision-making leading to the implementation of newborn health services and interventions within broader health programmes requires multiple actors and levels of involvement. We invite you to contribute to the next phase of the discussion.
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n31 January 2018
\n \n \n \nTo fight the growing global threat of antibiotic-resistant bacteria, food labels around the world should include an \u2018antibiotic footprint\u2019 section that clearly shows the type and amount of antibiotics used to produce that food, say scientists in a study led by Associate Professor Direk Limmathurotsakul.
\n \n\n \n \n\n \n\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n23 January 2018
\n \n \n \nThe fast spread of mobile phones across low-income countries like India can make it harder for poorer people without phones to access essential health services, new research by Dr Marco Haenssgen suggests.
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n5 December 2017
\n \n \n \nWellcome is announcing new collaborations with six institutions to find new ways to translate scientific discoveries into real world impact. The partnership with MORU will focus on closing the gap between research and implementing interventions, building capacity and expertise to support early translation to improve the health of people in low-income countries.
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n22 November 2017
\n \n \n \nProfessor Arjen Dondorp and colleagues are inching their way across the fringes of five Southeast Asian countries to test a triple combination therapy of antimalarial drugs. Results from the trial, being conducted in rural corners of Cambodia, Laos, Myanmar, Thailand and Vietnam, are due by mid-2018. This trial is also mentioned in the New York Times.
\n \n\n \n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n2 November 2017
\n \n \n \nA collaboration between the University of Oxford and Thailand\u2019s Mahidol University has been shortlisted for the prestigious 2017 Newton Prize for its project aiming to understand the early stages of scrub typhus in Thailand.
\n \n\n \n \n\n \n\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n13 October 2017
\n \n \n \nA new Oxford University collaboration between the BDI and the Centre for Tropical Medicine and Global Health will support understanding and action around one of the world\u2019s biggest health threats, drug-resistant infections.
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n10 October 2017
\n \n \n \nThe world\u2019s number-one treatment for malaria is on the brink of failure because of a new strain of drug-resistant parasites\u200a\u2014\u200aunless health policymakers take action. Professor Sir Nicholas White says that the mosquito-borne parasite responsible for severe malaria is now showing resistance to the prime treatment, Artemisinin Combination Therapy (ACT), across South-East Asia. If this resistance jumps to Africa, he warns, the tragedy will be on a massive scale.
\n \n\n \n \n\n \n\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n4 October 2017
\n \n \n \nA new typhoid vaccine for both adults and children has been proven by Oxford researchers to be safe and effective in preventing the disease. Professor Brian Angus participated in this study.
\n \n\n \n \n\n \n\n \n \n \n \n MOCRU\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n3 October 2017
\n \n \n \nMOCRU and its partner Medical Action Myanmar (MAM) have begun a study to identify areas in Myanmar where Burkholderia pseudomallei is present in the soil and where people are at risk of melioidosis, a difficult to diagnose deadly bacterial disease.
\n \n\n \n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n\n \n\n\n
\n \n\n \n27 September 2017
\n \n \n \nThe Universitas Indonesia Faculty of Medicine (FMUI) and the University of Oxford's Eijkman Oxford Clinical Research Unit (EOCRU, embedded with the Eijkman Institute of Molecular Biology, EIMB, and part of the Vietnam/Asia Wellcome research programme) have completed a facility dedicated to the support of the many collaborative clinical research activities between the two universities.
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n21 September 2017
\n \n \n \nA highly drug resistant malaria \"superbug\" from western Cambodia is now present in southern Vietnam, leading to alarming failure rates for dihydroartemisinin (DHA)-piperaquine \u2014 Vietnam\u2019s national first-line malaria treatment, leading malaria scientists warn.
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n SMRU\n \n \n\n \n\n\n
\n \n\n \n21 August 2017
\n \n \n \nChanging home designs and materials to make homes cooler and harder for mosquitoes to enter could reduce malaria transmission in sub-Saharan Africa, according to a new study in The Lancet Planetary Health.
\n \n\n \n \n\n \n\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n1 August 2017
\n \n \n \nThe amount of influenza-specific antibodies present in an individual\u2019s blood can indicate not only if they experienced the flu, but potentially when - a finding that could improve disease monitoring in the tropics, where flu season is unending.\r\n\r\nIn the largest study of its kind, an international team, led by researchers from the Oxford University Clinical Research Unit in Ho Chi Minh City, Vietnam, the Erasmus Medical Centre in Rotterdam, Netherlands, and Penn State University, identified antibody concentrations that correspond to recent and past exposure to the flu strain H1N1 - the strain involved in the 2009 flu pandemic.
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n19 July 2017
\n \n \n \nAn existing malaria rapid diagnostic test (RDT) can be adapted to predict the delayed anaemia that can complicate severe malaria in patients treated with artemisinin-based antimalarial drugs
\n \n\n \n \n\n \n\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n14 July 2017
\n \n \n \nResearchers from Oxford University Clinical Research Unit in Vietnam have shown that amphotericin B is more effective than itraconazole for the initial treatment of talaromycosis in HIV patients.
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n19 June 2017
\n \n \n \nOn Tues 6 June 2017, researchers vaccinated volunteers and began Mahidol University\u2019s study of the malaria vaccine RTS,S/AS01. This is the first study in Asia of the vaccine, an advanced product that has received regulatory approval in Europe.
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n19 June 2017
\n \n \n \nIt has been maintained for decades that quinine is the safest drug for treatment of malaria in the first trimester of pregnancy. In the largest analysis of data from Thailand and Africa, artemisinins are reported to be at least as safe as quinine. This will simplify treatment protocols worldwide.
\n \n\n \n \n